What type of study is this?

This is a Experimental Study study.

September 17, 2025Microbiological ResearchOpen Access

Novel plant-derived compounds modulate gut microbiome dysbiosis in colitis mice: A potential therapeutic avenue for inflammatory bowel disease

View Full Paper

Ask AI

Bookmark

Authors

MRMd. Mizanur RahamanAustralian Institute of Tropical Health and Medicine KYKarma YeshiAustralian Institute of Tropical Health and Medicine MBMehedi Hasan BappiGopalganj Science and Technology University

Discussion

Member takes

Implication

Study shows plant-derived compounds restore gut microbiome dysbiosis in colitis mice, suggesting a new therapeutic strategy for inflammatory bowel disease.

Key Points

Treatment with galloyl glucosides restored microbiome imbalance linked to inflammatory bowel disease.
Colitis significantly altered microbial composition, increasing harmful bacteria and reducing protective ones.
Assessment used PacBio HiFi sequencing on colon tissue to analyze gut microbiome changes.
Findings support galloyl glucosides as potential microbiome-targeted therapies for IBD treatment.

Cite This Study

Rahaman et al. (2025) studied this question.

synapsesocial.com/papers/68d46ccf31b076d99fa690b6 https://doi.org/10.1016/j.micres.2025.128343

View Full Paper

Ask AI

Bookmark

Implication

Study shows plant-derived compounds restore gut microbiome dysbiosis in colitis mice, suggesting a new therapeutic strategy for inflammatory bowel disease.

Novel plant-derived compounds modulate gut microbiome dysbiosis in colitis mice: A potential therapeutic avenue for inflammatory bowel disease

Discussion

Member takes

Implication

Key Points

Cite This Study

Novel plant-derived compounds modulate gut microbiome dysbiosis in colitis mice: A potential therapeutic avenue for inflammatory bowel disease

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider